cell and gene therapy
cell and gene therapy
Revolutionary Digital Twin Boosts AAV Production Efficiency!
🚀 MIT researchers unveil a digital twin for AAV production, optimizing yields and reducing costly experiments in gene therapy! 🌟🧬
Revolutionizing Therapy: Automation Slashes Production Costs!
🌟 Discover how automation and standardization in cell and gene therapy can significantly lower production costs and improve accessibility! 💡✅🤝
Andelyn Biosciences Boosts Gene Therapy Efficiency!
Andelyn Biosciences boosts AAV Curator™ platform with MyoAAV plasmids! 🚀 Enhancing gene therapy for muscles while reducing costs. 💪💰
Sana Biotechnology Launches New Facility in WA!
Sana Biotechnology celebrates a new biomanufacturing facility in Bothell, WA, boosting cell and gene therapy production! 🎉🏭🧑🔬📦🤝
MilliporeSigma Boosts Gene Therapy with $600M Acquisition!
MilliporeSigma acquires Mirus Bio for $600 million, boosting viral vector manufacturing and supporting gene therapy advancements! 🚀🔬💡🤝
Conquering Contamination in Gene Therapy Production
🌟 Overcoming sterility challenges in cell and gene therapy is vital! 🧬 Discover solutions for contamination risks and ensure quality! 🔬💡✨
Mastering Automation: The Key to Scaling Cell and Gene Therapy
🔬 Learn from other industries! 🏭 Lack of scale-up expertise is a challenge for CGT manufacturers. ⚙️ Master efficient manufacturing methods. 💰 Don't neglect late-stage trials and commercialization. 🤝 Hire experts. 🤖 Automation is crucial.
Breaking News: Gene Therapy Partnership Expands!
📢 Univercells Technologies and UPENN are expanding their partnership to evaluate gene therapy manufacturing scalability. 🧪 The goal is accessibility and cost reduction. 💪🏭👨🔬
Unlocking the Potential of Cell and Gene Therapies: The Game-Changing Solution
🧪 The cell and gene therapy market is growing rapidly, but development and manufacturing are complex. 🌍 SmartLabs offers a solution by hosting drug discovery, development, and manufacturing facilities in one location. 💰 This reduces costs and resources needed for non-scientific services, allowing companies to focus on developing robust processes. 💡 SmartLabs' modular facilities are customizable and phase-compliant, making it easier to transition through the drug development journey. 👥 Clients have access to expertise and support, and they retain control over their manufacturing process and IP. 🔬 SmartLabs aims to accelerate scientific breakthroughs and adapt to the evolving life sciences industry.
Breakthrough: Safer and Cheaper Alternative to Viral Vectors
📰 Overcoming Viral Vector Risks explores the limitations & risks of viral vectors in CGT manufacturing. ⚠️ FDA warnings & a safer alternative: electroporation. 💡
